Surging demand for firearms and ammunition have not resulted in a jump in share prices for gunmakers.» Read More
NEW YORK/ SAN ANTONIO, Dec 21- The coming weeks may well be a banner one for gun sales in America- and the massacre at a Connecticut elementary school will likely be a reason.
Take a look at some of Wednesday's midday movers.
There has been a shift in the debate about gun ownership. Until now, the debate has mainly centered on the social or second amendment issues, the right to bear arms. Suddenly, the conversation has moved to include investor responsibility—the power of money.
Dec 18- U.S. gun makers are facing pressure from some major U.S. investors after the Newtown elementary school shooting, with private equity firm Cerberus Capital Management LP announcing it would sell the largest U.S. manufacturer of firearms and major public pension funds reviewing their gun-related investments.
The tragedy of Sandy Hook has sent the stocks of gun makers plummeting, even as consumers appear to be flocking to buy new firearms.
*Dow up 0.8 pct, S&P 500 up 1 pct, Nasdaq up 1.4 pct. NEW YORK, Dec 18- U.S. stocks rose on Tuesday as investors positioned for a better economic environment as confidence grew a deal would be struck in Washington regarding the ongoing budget negotiations. The gains added to Monday's rally, giving the S&P 500 its best two-day run in a month.
Vanguard of Pennsylvania said in a statement it is "deeply saddened by the tragedy in Connecticut" but said most of its shares in Smith& Wesson and rival Sturm Ruger& Co are held in index funds that are required to track their indexes.
CNBC's Bertha Coombs reports Vanguard is a top holder in Smith & Wesson, and the firm is saying it cannot manage its funds to meet the "social concerns" of all shareholders.
Take a look at some of Tuesday's midday movers:
CNBC's Courtney Reagan reports Dick's Sporting Goods has suspended the sale of modern sporting rifles in all of its stores chainwide, and removed all guns from sale and from display in their store nearest to Newtown; and Dr. Tevi Troy, Hundson Institute senior fellow, weighs in on whether mental illness spending should be increased.
Should big institutions step up pressure on weapon makers, or stop funding them altogether? Dan Primack, Fortune senior editor, shares his opinions.
Cerberus announced it is selling Freedom Group and returning money to investors, reports CNBC's Mary Thompson.
While many special dividends have already been paid, Street.com has compiled a small collection of deals.
WASHINGTON-- Tennessee lawyer Brian Manookian says he never considered himself a gun enthusiast. He owns just one handgun and was raised in a gun-free home. An analysis by The Associated Press of data tracking the health of the gun industry shows that President Barack Obama has presided over a heyday for guns.
WASHINGTON-- President Barack Obama has presided over a heyday for the gun industry despite predictions by the National Rifle Association four years ago that he would be the "most anti-gun president in American history."
NEW YORK-- Benchmark Research believes the sell-off last week of shares in firearms manufacturers was overdone, and reiterated a buy recommendation on the stocks of the biggest producers.
U.S. stocks advanced on Wednesday after stronger-than-expected employment and service-sector data in the United States. But a gloomier outlook in China and Europe weighed on commodity prices and hit energy and materials shares. **SAREPTA THERAPEUTICS INC, $41.60, up 177 pct.
U.S. stocks rose on Wednesday after stronger-than-expected employment and service-sector data in the United States, but a gloomier outlook in China and Europe weighed on commodity prices and hit energy and materials shares. **SAREPTA THERAPEUTICS INC, $40.65, up 171 pct. **HEWLETT-PACKARD CO, $15.67, down 8.4 pct.
**SAREPTA THERAPEUTICS INC, $40.19, up 168 pct. **BIOLASE INC, $2.11, up 27 pct. The company said health regulators in Europe and the United States approved its laser device for use in soft tissue surgery, teeth whitening, and pain therapy.
Cramer makes the call on viewers' favorite stocks.